HAWKHILL THERAPEUTICS Ltd
New Filing
CIK: 0002140690·Biotechnology·UNITED KINGDOM·Filed: Jun 22, 2026
Total Offering
$192,569
Amount Sold
$192,569
Investors
1
First Sale
Apr 7, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Limited Liability Company
- Year Incorporated
- 2025
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Christopher Andrew Woodland | |
| Antoine Boulanger | |
| Mary Canning | |
| Francisca Peixoto | |
| Timothy Jason Sparey |
Company
SEC Filing
0002140690-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free